Ribobio Biotechnology Limited (06938.HK) and its subsidiary, Ribocure Pharmaceuticals AB, have successfully submitted an Investigational New Drug (IND) application for...
-
-
Recent Updates
- Stable Increase in Office Leasing Demand, AI Integration and Quality Upgrade Reshaping Corporate Real Estate Decisions
- Nippon Paint China Deepens Digital Collaboration with Alibaba Cloud
- Exploring Automotive AI Landscape at IAA 2026 Unveils Shifting Industry Dynamics
- Chinese Links in $2.5 Billion AI Chip Scandal Unveiled
- Contraband Convictions Unwrap in Chinese Export Case
- Emdoor Information Celebrates 18 Years in Rugged Computing: A Chinese Success Story
- Zoomlion’s Impressive Growth in Mining Machinery Sector and International Markets
- EU-China Preliminary Trade Deal to Significantly Cut Chinese EV Imports to EU
- Quantum Computing Initiatives Emerge with $350M Pentagon Boost
- China’s National Blockchain Network and Computing Power Plan
Blogroll